Market Access
BIO Boston: 2025 is shaping up to be a year of challenge – b...
What were the major themes to come out of BIO Boston 2025? Despite global events in the background, a fair amount of positivity.
R&D
From data to impact: How real-world evidence will transform ...
Real-world evidence (RWE) has moved from the periphery to the centre of how healthcare decisions are made.
Oncology
On the forefront of healthcare change, turning innovative sc...
Claus Zieler, chief commercial and medical affairs officer & member of the Executive Committee at Astellas Pharma, spoke with pharmaphorum at ASCO25.
Sales & Marketing
Closed & Collaborative H1 2025: Mergers, acquisitions, colla...
The first half of 2025 has been marked by a surge in strategic activity across the global healthcare, life sciences, and biotechnology sectors.
Oncology
A look back to ASCO 2025: Industry comments from iOnctura an...
ASCO 2025 may be over, but the insights for the future of oncology are only just beginning.
Sales & Marketing
Digital
Market Access
Editor's Picks
Editor's Picks